Setting 
My Cart
Toggle Nav
mobile icon
Close
  • Menu
  • Setting

Disease induced

Items 51-60 of 63

Page
per page
  1. Okadaic acid
    A4540 Okadaic acid
    Summary: Protein phosphatase 1 inhibitor
      Soluble in DMSO
  2. Streptozotocin
    A4457 Streptozotocin
     1 Citation
    Summary: Nitrosourea compound; for type 1 diabetes animal models
      ≥10.3 mg/mL
  3. Cyclophosphamide monohydrate
    A4232 Cyclophosphamide monohydrate
    Summary: alkylating, cytotoxic agent,antitumor activity
      ≥13.95 mg/mL
  4. Doxycycline hyclate
    A4052 Doxycycline hyclate
    Target: MMP
    Summary: matrix metalloproteinases inhibitor
      ≥22.15 mg/mL
  5. Aspirin (Acetylsalicylic acid)
    A4013 Aspirin (Acetylsalicylic acid)
    Summary: Cyclooxygenase (COX) inhibitor
  6. Doxorubicin
    A3966 Doxorubicin
     3 Citation
    Summary: DNA topoisomerase II inhibitor
      ≥27.2 mg/mL
  7. MPTP hydrochloride
    A3634 MPTP hydrochloride
    Summary: Dopaminergic neurotoxin,induced reduction in the DOPAC HVA/dopamine (DA) ratio
      ≥21 mg/mL
  8. Lactacystin (Synthetic)
    A2583 Lactacystin (Synthetic)
     1 Citation
    Target: Proteasome
    Summary: Proteasome inhibitor
      Soluble in H2O
  9. Cyclophosphamide
    A2343 Cyclophosphamide
    Summary: Alkylating chemotherapeutic agent; crosslinks DNA
      ≥11.85 mg/mL
  10. Dexamethasone (DHAP)
    A2324 Dexamethasone (DHAP)
     10 Citation
    Target: interleukin receptor
    Summary: Glucocorticoidan; anti-inflammatory
      insoluble in H2O; ≥19.623 mg/mL

Items 51-60 of 63

Page
per page